This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 49/1/193    most recent 01.HYP.0000250468.02084.cev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wenzel, S. Articles by Schlüter, K.-D. Search for Related Content PubMed PubMed Citation Articles by Wenzel, S. Articles by Schlüter, K.-D. Related Collections Other myocardial biology Other heart failure Remodeling Heart failure - basic studies Hypertrophy Oxidant stress

(Hypertension. 2007;49:193.)
© 2007 American Heart Association, Inc.

Original Articles

Lack of Endothelial Nitric Oxide Synthase–Derived Nitric Oxide Formation Favors Hypertrophy in Adult Ventricular Cardiomyocytes

Sibylle Wenzel; Cornelia Rohde; Sandra Wingerning; Joachim Roth; Georg Kojda; Klaus-Dieter Schlüter

From the Justus-Liebig-Universität Gießen (S. Wenzel, C.R., S. Wingerning, K.-D.S.), Physiologisches Institut, Gießen, Germany; Justus-Liebig-Universität Gießen (J.R.), Institut für Veterinärphysiologie, Gießen, Germany; and Heinrich-Heine-Universität Düsseldorf (G.K.), Institut für Pharmakologie und Klinische Pharmakologie, Düsseldorf, Germany.

Correspondence to Klaus-Dieter Schlüter, Justus-Liebig-Universität Gießen, Physiologisches Institut, Aulweg 129, D-35392 Gießen, Germany. E-mail Klaus-Dieter.Schlueter{at}physiologie.med.uni-giessen.de

Reduced activity and expression of endothelial NO synthase (eNOS) is observed in cardiomyocytes from pressure-overloaded hearts with heart failure. The present study was aimed to investigate whether reduced eNOS-derived NO production contributes to the hypertrophic growth and phenotype of these cardiomyocytes. Cultured ventricular cardiomyocytes from adult rats were exposed to N-nitro-L-arginine (L-NNA) to inhibit global NO formation, and cultured cardiomyocytes derived from eNOS-deficient mice were used as a model of genetic knockout of eNOS. Cell growth, formation of oxygen-derived radicals (reactive oxygen species [ROS]), activation of p38 mitogen-activated protein (MAP) kinase phosphorylation, and cytokine expression in cardiomyocytes were investigated. L-NNA caused a concentration-dependent acceleration of the rate of protein synthesis and an increase in cell size. This effect was sensitive to p38 MAP kinase inhibition or antioxidants. L-NNA induced a rapid increase in ROS formation, subsequent activation of p38 MAP kinase, and p38 MAP kinase–dependent increases in the expression of transforming growth factor-ß and tumor necrosis factor-. Similar changes (increased ROS formation, p38 MAP kinase phosphorylation, and cytokine induction) were also observed in cardiomyocytes derived from eNOS+/+ mice when exposed to L-NNA. Cardiomyocytes from eNOS–/– mice displayed higher p38 MAP kinase phosphorylation and cytokine expression under basal conditions, but neither these 2 parameters nor ROS formation were increased in the presence of L-NNA. In conclusion, our data support the hypothesis that reduced eNOS activity in cardiomyocytes contributes to the onset of myocardial hypertrophy and increased cytokine expression, which are involved in the transition to heart failure.

Key Words: myocardial hypertrophy • cytokine • TNF- • TGF-ß

This article has been cited by other articles:

				F. N. Salloum, A. Abbate, A. Das, J.-E. Houser, C. A. Mudrick, I. Z. Qureshi, N. N. Hoke, S. K. Roy, W. R. Brown, S. Prabhakar, et al. Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1398 - H1406. [Abstract] [Full Text] [PDF]

				G. Ruiz-Hurtado, M. Fernandez-Velasco, M. Mourelle, and C. Delgado LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation Hypertension, December 1, 2007; 50(6): 1049 - 1056. [Abstract] [Full Text] [PDF]